Nasal continuous positive airway pressure (nCPAP)
Nasal continuous positive airway pressure (nCPAP) is a medical device with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound
NIPPV vs.nCPAP During LISA Procedure
Ventilation Modalities and Acute Ischemic Stroke
Nasal High Frequency Oscillation for Respiratory Distress Syndrome in Twins Infants
NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)
Clinical Trials (10)
Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound
NIPPV vs.nCPAP During LISA Procedure
Ventilation Modalities and Acute Ischemic Stroke
Nasal High Frequency Oscillation for Respiratory Distress Syndrome in Twins Infants
NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)
Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction
The Effect of Nasal Continuous Positive Airway Pressure (N-CPAP) on Arterial pCO2 During Spinal Anesthesia
Cardiac Dysfunction in Obstructive Sleep Apnea Patients: Prevalence of and Effect of nCPAP
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10